15
Mar
2010
Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - Insomnia, XX - NJ
Somnus Therapeutics (Bedminster, NJ) a clinical-stage specialty pharmaceutical company focused on a delayed-release sleep-maintenance therapy, closed a $15M Series A financing. Participants include CTI Life Sciences Fund and Care Capital.